Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Patients Wih Leptomeningeal Metastasis of Breast Cancer. A Randomized Phase III Study.

NCT01645839 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT01645839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01645839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Patients Wih Leptomeningeal Metastasis of Breast Cancer. A Randomized Phase III Study.
Lead sponsor
Centre Oscar Lambret
Phase
Phase 3
Overall status
Completed
Start date
August 30, 2011
Completion date
March 1, 2019
Enrollment
74 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, leptomeningeal metastases